Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Many foods are packed with vitamin B, including meat (especially liver), fish, legumes, leafy greens, and seeds. Here’s a ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

Spend billions of dollars to cover anti-obesity drugs under Medicare and Medicaid, or deny more than 7 million people access ...

Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US ...

Discover how the obesity drug market is set to hit $173.5 billion by 2031, reshaping obesity and cardiometabolic treatments.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...